The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Agenus Inc | COM | 00847G705 | 9,739,335 | 6,407,457 | SH | SOLE | 6,407,457 | 0 | 0 | |||
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 89,743 | 448 | SH | SOLE | 448 | 0 | 0 | |||
Axsome Therapeutics Inc | COM | 05464T104 | 7,456,865 | 120,896 | SH | SOLE | 120,896 | 0 | 0 | |||
Biogen Inc | COM | 09062X103 | 36,866,778 | 132,600 | SH | SOLE | 132,600 | 0 | 0 | |||
Biomarin Pharmaceutical Inc | COM | 09061G101 | 34,912,563 | 359,035 | SH | SOLE | 359,035 | 0 | 0 | |||
bluebird bio Inc | COM | 09609G100 | 2,139,552 | 672,815 | SH | SOLE | 672,815 | 0 | 0 | |||
Celldex Therapeutics Inc | COM | 15117B202 | 15,089,904 | 419,397 | SH | SOLE | 419,397 | 0 | 0 | |||
Chinook Therapeutics Inc | COM | 16961L106 | 23,204,356 | 1,002,348 | SH | SOLE | 1,002,348 | 0 | 0 | |||
CTI Biopharma Corp | COM | 12648L601 | 11,737,076 | 2,794,542 | SH | SOLE | 2,794,542 | 0 | 0 | |||
Cytokinetics Inc | COM | 23282W605 | 12,450,081 | 353,796 | SH | SOLE | 353,796 | 0 | 0 | |||
Dexcom Inc | COM | 252131107 | 29,884,633 | 257,227 | SH | SOLE | 257,227 | 0 | 0 | |||
Eli Lilly and Co | COM | 532457108 | 47,082,882 | 137,100 | SH | SOLE | 137,100 | 0 | 0 | |||
Exelixis Inc | COM | 30161Q104 | 16,134,427 | 831,243 | SH | SOLE | 831,243 | 0 | 0 | |||
Geron Corp | COM | 374163103 | 17,956,516 | 8,274,892 | SH | SOLE | 8,274,892 | 0 | 0 | |||
Horizon Therapeutics PLC | SHS | G46188101 | 44,618,506 | 408,819 | SH | SOLE | 408,819 | 0 | 0 | |||
IDEAYA Biosciences Inc | COM | 45166A102 | 6,221,736 | 453,149 | SH | SOLE | 453,149 | 0 | 0 | |||
Immatics NV | SHS | N44445109 | 21,615,589 | 3,132,694 | SH | SOLE | 3,132,694 | 0 | 0 | |||
ImmunoGen Inc | COM | 45253H101 | 3,840,000 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | ||
ImmunoGen Inc | COM | 45253H101 | 3,550,203 | 924,532 | SH | SOLE | 924,532 | 0 | 0 | |||
Inhibrx Inc | COM | 45720L107 | 23,483,489 | 1,244,488 | SH | SOLE | 1,244,488 | 0 | 0 | |||
Intuitive Surgical Inc | COM | 46120E602 | 38,215,502 | 149,589 | SH | SOLE | 149,589 | 0 | 0 | |||
IVERIC bio Inc | COM | 46583P102 | 22,042,542 | 905,982 | SH | SOLE | 905,982 | 0 | 0 | |||
Karuna Therapeutics Inc | COM | 48576A100 | 124,060 | 683 | SH | SOLE | 683 | 0 | 0 | |||
Keros Therapeutics Inc | COM | 492327101 | 3,292,170 | 77,100 | SH | SOLE | 77,100 | 0 | 0 | |||
Kura Oncology Inc | COM | 50127T109 | 7,535,747 | 616,169 | SH | SOLE | 616,169 | 0 | 0 | |||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 8,282,684 | 1,200,389 | SH | SOLE | 1,200,389 | 0 | 0 | |||
Merck & Co Inc | COM | 58933Y105 | 89,529,526 | 841,522 | SH | SOLE | 841,522 | 0 | 0 | |||
Novocure Ltd | ORD SHS | G6674U108 | 3,007,000 | 50,000 | SH | Call | SOLE | 50,000 | 0 | 0 | ||
Prometheus Biosciences Inc | COM | 74349U108 | 13,290,723 | 123,842 | SH | SOLE | 123,842 | 0 | 0 | |||
PTC Therapeutics Inc | COM | 69366J200 | 25,048,082 | 517,095 | SH | SOLE | 517,095 | 0 | 0 | |||
Reata Pharmaceuticals Inc | CL A | 75615P103 | 57,068,938 | 627,683 | SH | SOLE | 627,683 | 0 | 0 | |||
Revolution Medicines Inc | COM | 76155X100 | 3,981,931 | 183,838 | SH | SOLE | 183,838 | 0 | 0 | |||
Sarepta Therapeutics Inc | COM | 803607100 | 16,410,729 | 119,065 | SH | SOLE | 119,065 | 0 | 0 | |||
SPDR S&P 500 ETF Trust | TR UNIT | 78462F103 | 81,878,000 | 200,000 | SH | Put | SOLE | 200,000 | 0 | 0 | ||
Syndax Pharmaceuticals Inc | COM | 87164F105 | 22,712,955 | 1,075,424 | SH | SOLE | 1,075,424 | 0 | 0 | |||
Travere Therapeutics Inc | COM | 89422G107 | 28,421,085 | 1,263,721 | SH | SOLE | 1,263,721 | 0 | 0 | |||
Vir Biotechnology Inc | COM | 92764N102 | 15,301,398 | 657,559 | SH | SOLE | 657,559 | 0 | 0 | |||
Zentalis Pharmaceuticals Inc | COM | 98943L107 | 24,751,866 | 1,439,062 | SH | SOLE | 1,439,062 | 0 | 0 | |||
Aerovate Therapeutics Inc | COM | 008064107 | 75,812,697 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | |||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 80,847,311 | 754,032 | SH | SOLE | 754,032 | 0 | 0 | |||
Bolt Biotherapeutics Inc | COM | 097702104 | 3,828,667 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | |||
Fusion Pharmaceuticals Inc | COM | 36118A100 | 441,463 | 117,099 | SH | SOLE | 117,099 | 0 | 0 | |||
Galera Therapeutics Inc | COM | 36338D108 | 7,894,303 | 3,083,712 | SH | SOLE | 3,083,712 | 0 | 0 | |||
Inozyme Pharma Inc | COM | 45790W108 | 20,944,915 | 3,655,308 | SH | SOLE | 3,655,308 | 0 | 0 | |||
Karuna Therapeutics Inc | COM | 48576A100 | 321,946,183 | 1,772,441 | SH | SOLE | 1,772,441 | 0 | 0 | |||
Natera Inc | COM | 632307104 | 172,143,091 | 3,100,560 | SH | SOLE | 3,100,560 | 0 | 0 | |||
Nextcure Inc | COM | 65343E108 | 3,954,347 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | |||
Nucana PLC | SPONSORED ADR | 67022C106 | 5,376,559 | 5,599,999 | SH | SOLE | 5,599,999 | 0 | 0 | |||
Nucana PLC | COMMON SHARES | GB00BYWYV | 2,304,240 | 2,400,000 | SH | SOLE | 2,400,000 | 0 | 0 | |||
PDS Biotechnology Corp | COM | 70465T107 | 877,205 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | |||
Synlogic Inc | COM | 87166L100 | 363,382 | 574,972 | SH | SOLE | 574,972 | 0 | 0 | |||
Vera Therapeutics Inc | CL A | 92337R101 | 26,905,131 | 3,467,156 | SH | SOLE | 3,467,156 | 0 | 0 | |||
Y-mAbs Therapeutics Inc | COM | 984241109 | 10,993,333 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 |